New Drug of the day : Rufinamide

Rufinamide, a presumed sodium channel modulator, was licensed for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome.

(for further : see 11th edition of Goodman & Gilman, pages 501-525).